September 16, 2020
Early detection and intervention stanched the first known introductions of the SARS-CoV-2 virus into North America and Europe, validating the effectiveness of quick, comprehensive testing and contact tracing, but inadequate public health measures allowed the virus to take hold.
February 7, 2019
UC San Diego Health performed its 4,000th pulmonary thromboendarterectomy (PTE), a lifesaving surgery to clear the lung’s arteries of scar-like tissue that robs patients of their ability to breathe.
October 9, 2024
El Centro Mayor, Sylvia Marroquin, shares her journey with kidney cancer and how a clinical trial at UC San Diego Health saved her life.
February 27, 2019
Researchers at UC San Diego School of Medicine have identified a clear group of characteristics that predict heightened risk for experiencing increased anxiety or worsening of mood that interferes with daily activities when using a smoking cessation drug.
March 9, 2017
…Dykes, UC San Diego Health Before Dr. Sonia Ramamoorthy, chief of colon and rectal surgery at UC San Diego Health, took a scalpel to Larry Smarr, director of Calit2, she first took a virtual tour of his large intestine. It encompassed an entire room. Then Smarr, Harry E. Gruber Professor…
September 17, 2020
…remain a significant public health threat until there is an effective vaccine and some degree of herd immunity.” If humans face the prospect of living with the dual threats of COVID-19 and influenza for at least part of every year, there are things to know and things to do to…
June 9, 2016
…criminal problem. It’s a health problem.” From left, Richard Branson and Steffanie Strathdee Branson, who has become a major voice in the global drug policy debate, visited UC San Diego last week to participate in a panel discussion on global drug decriminalization and Tijuana’s HIV/AIDS epidemic, which is fueled in…
August 5, 2020
The National Institutes of Health will soon launch a Phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthetic monoclonal antibodies. Davey Smith of UC San Diego is the protocol chair and answers questions.
October 13, 2015
Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling them to respond to, ensnare and kill bacteria in laboratory experiments. Tamoxifen treatment in mice also…
October 12, 2018
…study at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response.
